IRIS
SACCANI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.157
AS - Asia 1.794
EU - Europa 1.438
SA - Sud America 215
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 5.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.101
CN - Cina 607
SG - Singapore 561
FI - Finlandia 344
VN - Vietnam 293
SE - Svezia 278
IE - Irlanda 231
BR - Brasile 169
DE - Germania 132
HK - Hong Kong 120
IT - Italia 115
UA - Ucraina 73
TR - Turchia 59
FR - Francia 57
ZA - Sudafrica 55
GB - Regno Unito 45
NL - Olanda 45
CA - Canada 39
IN - India 36
AT - Austria 33
AR - Argentina 25
BD - Bangladesh 23
ES - Italia 17
BE - Belgio 16
CI - Costa d'Avorio 15
PH - Filippine 13
RU - Federazione Russa 13
CZ - Repubblica Ceca 12
JP - Giappone 12
MX - Messico 12
EC - Ecuador 9
IQ - Iraq 9
PK - Pakistan 8
PL - Polonia 8
ID - Indonesia 7
LT - Lituania 7
TH - Thailandia 7
KR - Corea 6
EG - Egitto 5
EU - Europa 5
MA - Marocco 5
TW - Taiwan 5
ET - Etiopia 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
KE - Kenya 3
SN - Senegal 3
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.704
Salva come PNG Salva come JPEG
Città #
Singapore 319
Ashburn 282
Chandler 277
Dublin 231
Beijing 153
Dallas 127
Santa Clara 126
San Jose 124
Hong Kong 111
Dearborn 95
Jacksonville 95
Ho Chi Minh City 92
Boardman 84
Parma 81
New York 77
Nanjing 65
Shanghai 62
Hanoi 58
Munich 53
Johannesburg 52
Ann Arbor 48
Izmir 44
Princeton 38
Lauterbourg 34
Los Angeles 34
Vienna 29
Buffalo 25
Helsinki 25
Wilmington 24
San Mateo 23
Nanchang 22
Kunming 20
Hebei 18
Toronto 18
Bremen 16
Brussels 16
Jinan 16
Abidjan 15
Seattle 15
São Paulo 15
Des Moines 14
Guangzhou 14
Haiphong 14
Hefei 14
London 12
Montreal 11
Pune 11
Shenyang 11
Brooklyn 10
Tianjin 10
Tokyo 10
Turku 10
Brno 9
Changsha 9
Council Bluffs 9
Denver 9
Houston 9
Zhengzhou 9
Hangzhou 8
Jiaxing 8
Norwalk 8
Poplar 8
Stockholm 8
Warsaw 8
Bắc Ninh 7
Da Nang 7
Ottawa 7
Rio de Janeiro 7
Can Tho 6
Chennai 6
Chicago 6
Dhaka 6
Frankfurt am Main 6
Hải Dương 6
New Delhi 6
Phoenix 6
Atlanta 5
Boston 5
Columbus 5
Manchester 5
Marseille 5
Moscow 5
Ankara 4
Augusta 4
Bangkok 4
Bến Tre 4
Chengdu 4
Erbil 4
Fremont 4
Quito 4
Redondo Beach 4
Woodbridge 4
Addis Ababa 3
Baghdad 3
Baku 3
Biên Hòa 3
Brasília 3
Cairo 3
Chongqing 3
Dakar 3
Totale 3.472
Salva come PNG Salva come JPEG
Nome #
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 196
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 187
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 180
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 180
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 174
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 174
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 173
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 169
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 168
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 166
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 166
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 166
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 163
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 161
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 160
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 159
Analgesic activity of new hybrid muscarinic agonists in mice 159
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 157
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 154
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 153
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 152
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 150
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 147
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 146
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 144
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 143
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 141
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 140
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 138
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 135
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 127
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 122
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 121
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 108
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 104
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 99
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 89
Totale 5.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 14 32 0
2021/2022171 2 0 0 24 6 3 23 21 8 10 9 65
2022/2023971 116 130 61 85 81 112 23 38 266 2 46 11
2023/2024330 15 18 4 12 23 92 32 35 18 6 25 50
2024/2025906 26 44 51 63 100 100 32 31 119 74 84 182
2025/20262.030 275 170 204 248 307 142 182 65 315 122 0 0
Totale 5.747